genelabs(gnlb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : genelabs(gnlb)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMarcus who wrote (119)	3/19/1998 4:54:00 PM
From: Biotech	of 233

The press release on 3/3/98 concerning GNLB's agreements with Tripos, MDS Panlabs and SRI Intl is a very important announcement. First-off, Tripos is a well respected firm and is a technology leader. Secondly, by capturing these combinatorial chemistry libraries, GNLB's has additional libraries of molecules to analyze with Merlin. Lastly, as the press release reads, SRI Intl will produce molecules made to GNLB specifications. This says to me that GNLB is closer to beginning live testing of its molecules. It is getting interesting!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next